Heart failure with preserved ejection fraction (HFpEF) stands out as a major public health threat and presents with unique demographic and comorbidity profiles in Asian populations, indicating distinct underlying mechanisms. To showcase studies designed to bridge mechanistic gaps, overcome translational hurdles, and spark innovation, JACC: Asia invites investigators with corresponding or first authors based in Asia to submit original research articles related to HFpEF research and therapy. Learn more and submit by Feb. 15, 2026.